Title: | Spinal muscular atrophy |
Journal : | Lancet (Ed. ang.), 371, 9630 |
Authors: | Lunn MR ; Wang CH |
Material Type: | Article |
Publication Date: | 21/06/2008 |
Size: | p. 2120-2133 |
Languages: | English |
Keywords : | carnitine ; clinical trials ; creatine ; diseases classifications ; gabapentine ; genetic mutations ; growth hormone ; histopathology ; hydroxyurea ; medical treatment ; modes of action ; molecular biology ; molecular genetics ; phenylbutyric acid ; proximal spinal muscular atrophy type 1 ; proximal spinal muscular atrophy type 3 ; proximal spinal muscular atrophy type 4 ; review article ; riluzole ; salbutamol ; SMN1 gene ; spinal cord ; spinal muscular atrophy ; thyrotrophin ; valproic acid |
Abstract: |
Accès au résumé PubMed / to PubMed abstract |
Lien associé : | http://www.ncbi.nlm.nih.gov/pubmed/18572081?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum |